Alembic Pharma reported its consolidated financial results for the quarter and a half year that ended on 30th September 2022.
The pharma company has registered a 12.3 percent rise in its consolidated revenues quarter on quarter, with the company’s revenue for the second quarter stood at Rs 1,437.34 crores against Rs 1,313.19 crores in the same quarter last year.
The company reported that the net sales for the quarter were up 14% to Rs. 1475 crores and net profit for the quarter at Rs. 133 crores.
In an exclusive conversation with CNBC-TV18, RK Baheti, CFO, Alembic Pharmaceuticals, speaks on the firm's Q2FY23 results. Listen in.
#alembcipharmaceutical #Q2FY23results #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday
About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.
You can also connect with CNBC-TV18 News Online
Catch the latest news: [ Ссылка ]
Follow CNBC-TV18 round the clock: [ Ссылка ]
Stay updated with all the market action in real time: [ Ссылка ]
You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: [ Ссылка ]
Subscribe to our Channel: [ Ссылка ]
Like us on Facebook: [ Ссылка ]
Follow us on Twitter: [ Ссылка ]
n18oc_business
